A drug-use and disease-state management (DUDSM) program was instituted in 1
996 at a teaching hospital associated with a large nonprofit health care sy
stem.
The program's goals are to optimize pharmacotherapeutic regimens, evaluate
health outcomes of identified disease states, and evaluate the economic imp
act of pharmacotherapeutic options for given disease states by developing p
ractice guidelines. Through a re-engineering process, resources within the
pharmacy department were identified that could be devoted to the DUDSM prog
ram, including the use of clinical pharmacy specialists, promotion of staff
pharmacists into the DUDSM program, a pharmacy technician, and information
systems support. A strength of the program is its systematic approach for
developing and implementing new initiatives, as well as monitoring complian
ce with all initiatives on an ongoing basis. The initiative-design process
incorporates continuous quality improvement principles, outcome design and
evaluation, competency assessment for all pharmacists, multidisciplinary co
llaboration, and sophisticated information systems. Seventy-five initiative
s have been implemented, ranging from simple dose-optimization strategies f
or specific drugs to complicated practice guidelines for managing specific
disease states. Improved patient outcomes have been documented, including r
educed length of stay, postsurgical wound infection, adverse drug reactions
, and medication errors. Documented cost savings exceeded $4 million annual
ly for fiscal years 1996-97 through 1999-2000. Overall compliance with DUDS
M initiatives exceeds 80%, and physician service profiling has been initiat
ed to monitor variant prescribing.
The DUDSM program has successfully integrated practice guidelines into ther
apeutic decision-making, resulting in improved patient-care outcomes and co
st savings.